QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

City of Industry, CA -- (SBWire) -- 08/20/2018 --This report studies the global Drug Eluting Balloons (DEBs) market status and forecast, categorizes the global Drug Eluting Balloons (DEBs) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).

Open heart surgeries and open peripheral surgeries can be life-threating as they involve several complications. This is compelling surgeons to adopt MI techniques over traditional techniques since they ensure high accuracy, faster recovery, fewer post-surgery infections, reduced hospital stays and incision marks, and minimal complications. This will increase the demand for DEBs since they enhance surgical precision by providing a 3D view of the patient and allows the insertion of DEBs in an individual's body by enabling the manipulation of small surgical tools.

The DEBs market is characterized by the presence of several players. Vendors are coming up with various advanced technologies such as IN.PACT Admiral, Lutonix 035, SeQuent Please Neo, Elutax SV, Freeway, Advance 18 PTX and DIOR. This will drive the demand for DEBs and increase the sales volume and profit margins of vendors. The availability of a substantial number of CE approved DEB products, an increase in the number of clinical trials, and the approval of certain DEB products by the US FDA, will offer significant growth opportunities to the vendors.

The major players covered in this report

B. Braun Melsungen

Cook Medical

C.R. Bard

Eurocor

Medtronic

Aachen Resonance

Acrostak

Cardionovum

Spectranetics

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/627626/global-drug-eluting-balloons-debs-sales-market

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/38b06ce7710749aedcc79e54abaaee7d,0,1

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.